Pancreatic Cancer Research

ResearcherAnhui Medical UniversityActive in the last 2 years

Wei Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3117-9598; OpenAlex author ID A5100323703. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217713↗
  2. Combining Single-Cell and Transcriptomic Data Revealed the Prognostic Significance of Glycolysis in Pancreatic Cancer. Co-author DOI 10.3389/fgene.2022.903783↗
  3. LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity. Co-author DOI 10.1016/j.yexcr.2020.111984↗
  4. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin. Co-author DOI 10.1016/j.pan.2013.05.008↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yixuan Zhang · 1 shared paper, 2025 · strength 0.20
  2. Jiatong Tang · 1 shared paper, 2025 · strength 0.20
  3. Neng Tang · 1 shared paper, 2025 · strength 0.20
  4. Chao Yan · 1 shared paper, 2025 · strength 0.20
  5. Hexing Hang · 1 shared paper, 2025 · strength 0.20
  6. Yudong Qiu · 1 shared paper, 2025 · strength 0.20
  7. Hao Cheng · 1 shared paper, 2025 · strength 0.20
  8. Xiaohong Shen · 2 shared papers, 2013–2020 · strength 0.19
  9. Shaoxia Du · 1 shared paper, 2020 · strength 0.15
  10. Hui Wang · 1 shared paper, 2020 · strength 0.15
  11. Jun Cai · 1 shared paper, 2020 · strength 0.15
  12. Hongzhu Yu · 1 shared paper, 2022 · strength 0.14
  13. Liang Chen · 1 shared paper, 2022 · strength 0.14
  14. Qiang Li · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.